Get the Daily Brief
Latest Biotech News
FDA Speed Review Voucher Program Sparks Debate
The Food and Drug Administration (FDA) recently announced a pilot program offering expedited priority review vouchers to U.S. companies aligning drug development with national public health...
Lilly Acquires Verve Therapeutics in $1.3B Gene Editing Deal
Eli Lilly has agreed to acquire Verve Therapeutics for up to $1.3 billion, marking a major investment in gene-editing therapies targeting cardiovascular disease. Verve’s lead candidate, VERVE-102,...
Pediatric Oncology Advances with Genomic and Immunotherapy Innovations
Pediatric oncology research is witnessing significant enhancements through advanced genomic profiling and novel immunotherapeutic strategies. The Princess Máxima Center has implemented...
AI Accelerates Protein Design and Drug Discovery
Artificial intelligence is rapidly transforming protein engineering and drug development. European Molecular Biology Laboratory researchers introduced AlphaDesign, an AI-driven framework building...
Novel Immunotherapies and Biomarker Programs Target Lung and Pancreatic Cancer
The lung and pancreatic cancer treatment landscapes are evolving with the introduction of innovative immunotherapies and diagnostic tools. Ivonescimab, a PD-1/VEGF bispecific antibody, gained...
Breakthrough Neural and Autoimmune Therapies Gain Momentum
Emerging treatments for autoimmune and neurodegenerative diseases demonstrate encouraging progress. A humanized monovalent antibody therapy targeting anti-NMDA receptor encephalitis has been...
Breakthrough AI Tools Enhance Biomedical Imaging and Diagnostics
Innovative computational methods are elevating biomedical analysis. Researchers at Virginia Commonwealth University developed TACIT, an AI algorithm enabling rapid, high-precision cell type...
Environmental and Agricultural Innovations Target Sustainability Challenges
Sustainability-focused research reveals promising advances. University of Nottingham discovered surface patterns that resist bacterial colonization on plastics, with implications for preventing...
Alarming Safety Concerns in Muscular Dystrophy Gene Therapy
Sarepta Therapeutics faces heightened scrutiny after reporting a second patient death linked to its gene therapy Elevidys for Duchenne muscular dystrophy (DMD). Both fatalities involved acute...
Draig Therapeutics Launches with $140M Series A for Depression Portfolio
Draig Therapeutics, a UK-based biotech emerging from stealth, secured a $140 million Series A funding round to advance its neuropsychiatry pipeline. The financing, backed notably by Sanofi's...
FDA Suspends Sarepta’s Muscular Dystrophy Gene Therapy After Second Patient Death
Sarepta Therapeutics has halted shipments of its gene therapy Elevidys for Duchenne muscular dystrophy in older, non-ambulatory patients following a second reported death linked to acute liver...
Progress in Pan-KRAS Inhibitors Fueled by AI-Driven Design Platforms
Insilico Medicine announced the design of novel pan-KRAS inhibitors through its Chemistry42 AI platform, overcoming challenges associated with KRAS’ undruggable nature. Utilizing structure-based...
Eli Lilly Acquires Verve Therapeutics in $1.3 Billion Gene Editing Deal
Eli Lilly announced its acquisition of Verve Therapeutics for up to $1.3 billion, integrating Verve's gene-editing technology targeting cardiovascular disease into its pipeline. Verve's lead...
Breakthrough Single-Cell Analysis Elucidates Systemic Sclerosis Heterogeneity
Researchers utilizing single-cell RNA sequencing and spatial transcriptomics disclosed immune cell subsets implicated in the clinical variability of systemic sclerosis. Specific monocyte and CD8+...
Novel Dual Immunotherapy Gains Global Approval in Liver Cancer First-Line Treatment
The University of Hong Kong developed a dual checkpoint inhibitor therapy combining nivolumab and ipilimumab for unresectable hepatocellular carcinoma, receiving authorization across multiple...
Calibr-Skaggs Starts Phase 1 Trial of Switchable CAR-T Therapy for Metastatic Breast Cancer
Calibr-Skaggs launched the first-in-human clinical study testing a modular 'switchable' CAR-T therapy platform designed to improve control and safety in solid tumor treatments. The Phase 1 trial...
Yale Scientists Advance Multiplexed Precision Human Gene Editing
Yale University researchers developed an enhanced multiplex genome editing technique, significantly increasing the number of accurate edits per cell while minimizing off-target mutations. This...
Rice University Unveils Quantum Materials Breakthrough via Chiral Photonic Crystal Cavities
Rice researchers, led by Junichiro Kono, engineered a novel photonic-crystal cavity integrating lightly doped indium antimonide to preferentially enhance vacuum fluctuations of circularly...
Stanford Identifies Key Yew Tree Enzymes to Boost Cancer Drug Biosynthesis
Stanford scientists discovered missing enzymes critical for the biosynthesis of taxol, a vital chemotherapy drug sourced from yew trees. Utilizing single-nucleus RNA sequencing on stressed yew...
Verve Therapeutics Acquisition: Lilly’s $1.3B Bet on Gene Editing
Eli Lilly has agreed to acquire Verve Therapeutics for up to $1.3 billion, including milestone payments contingent on clinical progress. Verve’s lead gene-editing candidate, VERVE-102, targets...